Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The generation, dissemination, and sharing of research data are key ingredients in contributing to scientific progress and the public good. Data sharing has been encouraged to facilitate open science within the clinical research enterprise, improve the development of drugs and devices, and benefit public health.1 But sharing data is complex. Investigators generally tend to guard research data to retain ownership and property rights, avoid competition, protect confidentiality and privacy, or avoid misuse by unqualified persons. Sharing research data also comes at a cost to the sharer. This Viewpoint examines some approaches and cost considerations involved in sharing participant-level clinical research data.
Wilhelm EE, Oster E, Shoulson I. Approaches and Costs for Sharing Clinical Research Data. JAMA. 2014;311(12):1201–1202. doi:10.1001/jama.2014.850
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: